News in English
Декабрь
2024
22
23
24
25
26
27
28
29
30
31

Новости за 18.12.2024

Top Stories (us) - Google News (com) 

Disney cuts transgender storyline from upcoming Pixar show - Euronews

  1. Disney cuts transgender storyline from upcoming Pixar show  Euronews
  2. ‘Win Or Lose’ Transgender Actress Speaks Out After Disney Cuts Her Storyline: “Very Disheartened”  Deadline
  3. Black Trans Actress Responds to Disney Axing Her Character's Transgender Storyline From Upcoming Pixar Series  The Root
  4. ‘Win or Lose:’ Disney cuts transgender storyline from new animated series | CNN Business  CNN
  5. Disney Cuts Trans Storyline From Pixar's 'Win or Lose' Series  Variety

TheSun.co.uk 

Why Marcus Rashford joining Arsenal is perfect fit but £325k-a-week Man Utd ace must first choose between cash or career

MARCUS Rashford is at a crossroads.

But now the England star has to make the biggest choice he has ever faced – does he care about cash, or about his career?

GettyMarcus Rashford has admitted he is ‘ready for a new challenge’[/caption] GettyRashford could be a good fit at Arsenal under Mikel Arteta[/caption]

Rashford’s shock admission that he is “ready for a new challenge” after some two decades under the Manchester United umbrella has altered the dynamic around his future. Читать дальше...

Wardsauto.com 

SDV Market Tracker: 2024 Analysis

Wards Intelligence’s SDV Market Tracker reveals that U.S. automakers currently dominate the global software-defined vehicle (SDV) market, with Tesla’s Model Y and Model 3 projected to be the top-selling SDVs in 2024. However, Chinese OEMs are on track to overtake and assume market leadership in the near future.

Top Stories (us) - Google News (ru) 

Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist - Merck

  1. Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist  Merck
  2. Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal  CNBC
  3. Live news: Merck strikes $2bn deal with Chinese biotech to develop oral weight-loss drug  Financial Times
  4. Merck in Pact for Chinese Obesity Drug in Nearly $2 Billion Deal  Bloomberg
  5. Merck & Co. boosts GLP-1 portfolio by paying $112M... Читать дальше...